iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionFulton Breakefield Broenniman Llc
Latest Disclosed Ownership1,978 shares
Latest Disclosed Value $ 333,994
Fulton Breakefield Broenniman Llc ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On April 27, 2026 - Fulton Breakefield Broenniman Llc filed a 13F-HR form disclosing ownership of 1,978 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $333,994 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 1,978 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $259,217 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,978 0 0.00 334 0.00 0.0218
2026-01-21 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,978 0 0.00 334 16.84 0.0211
2025-10-16 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,978 -37 -1.84 286 12.20 0.0184
2025-07-23 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,015 37 1.87 255 0.79 0.0172
2025-05-01 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,978 -633 -24.24 253 -26.96 0.0183
2025-01-23 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,611 0 0.00 345 -9.21 0.0247
2024-10-16 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,611 -76 -2.83 380 3.26 0.0265
2024-08-07 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,687 0 0.00 369 0.00 0.0272
2024-04-29 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,687 0 0.00 369 0.82 0.0284
2024-02-02 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,687 -28 -1.03 365 10.27 0.0294
2023-10-20 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,715 16 0.59 332 -3.22 0.0289
2023-07-19 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,699 12 0.45 343 -1.44 0.0283
2023-04-25 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,687 -200 -6.93 347 -8.20 0.0298
2023-02-15 2022-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 2,887 1 0.03 379 11.83 0.0336
2023-01-31 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,887 1 0 0.0336
2022-10-17 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,886 0 0.00 338 -0.59 0.0318
2022-07-28 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,886 0 0.00 340 -9.57 0.0294
2022-04-27 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,886 -452 -13.54 376 -26.13 0.0331
2022-02-07 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,338 452 15.66 509 8.99 0.0377
2021-10-25 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,886 -31 -1.06 467 -2.10 0.0400
2021-07-27 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,917 -29 -0.98 477 7.43 0.0408
2021-04-09 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,946 612 26.22 444 25.42 0.0411
2021-01-14 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,334 -573 -19.71 354 -10.15 0.0424
2020-10-20 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,907 -39 -1.32 394 -2.23 0.0444
2020-07-10 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,946 200 7.28 403 36.15 0.0490
2020-04-10 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,746 -132 -4.59 296 -14.70 0.0442
2020-01-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,878 0 0.00 347 21.33 0.0405
2019-10-17 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,878 2,878 286 0.0364
2016-08-02 2016-06-30 13F IBB COM 464287556 0 -10,406 -100.00 0 -100.00
2016-05-06 2016-03-31 13F IBB COM 464287556 10,406 -286 -2.67 2,714 -24.99 0.5941
2016-01-29 2015-12-31 13F IBB COM 464287556 10,692 -416 -3.75 3,618 7.39 0.7999
2015-11-09 2015-09-30 13F IBB COM 464287556 11,108 -615 -5.25 3,369 -22.12 0.7945
2015-08-04 2015-06-30 13F IBB COM 464287556 11,723 -127 -1.07 4,326 6.29 0.9465
2015-04-08 2015-03-31 13F IBB COM 464287556 11,850 11,850 0.00 4,070 0.9062
2015-01-28 2014-12-31 13F iShares Nasdaq Biotechnology S COM 464287556 0 -11,853 -100.00 0 -100.00
2014-11-06 2014-09-30 13F iShares Nasdaq Biotechnology S COM 464287556 11,853 198 1.70 3,243 8.28 0.7590
2014-07-24 2014-06-30 13F iShares Nasdaq Biotechnology S COM 464287556 11,655 803 7.40 2,995 16.76 0.7255
2014-04-25 2014-03-31 13F iShares Nasdaq Biotechnology S COM 464287556 10,852 10,852 2,565 0.6613
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.